Providing early antiretroviral drug treatment for recently infected HIV patients and their uninfected sexual partners is a cost-effective way to help patients stay healthy and prevent transmission of HIV, a new study finds. Rochelle Walensky and Kenneth Freedberg, both HMS professors of medicine at Massachusetts General Hospital, led the study.
